🔎 Trials Near Me

Utama › Penyakit Parkinson › Michigan › Farmington Hills

Kajian klinikal Penyakit Parkinson di Farmington Hills, MI

13 kajian untuk Penyakit Parkinson sedang mencari peserta di lokasi dalam dan sekitar Farmington Hills (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Mengambil pesertaFasa 2
  • Quest Research Institute, Farmington Hills
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06680830

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
  • Quest Research Institute - Alcanza, Farmington Hills
Umur 30 hingga 80 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06565195

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Mengambil pesertaFasa 2/3
  • Site-015, Farmington Hills
Umur 40 hingga 80 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06976268

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Mengambil pesertaFasa 2
  • Quest Research Institute, Farmington Hills
Umur 40 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07005180

A Study of Buntanetap in Participants With PD

Mengambil pesertaFasa 2/3
  • Quest Research Institute, Farmington Hills
Umur 40 hingga 85 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07284784

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Mengambil pesertaFasa 2
  • Vima Site #002, Farmington Hills
Umur 18 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Mengambil pesertaFasa 2
  • Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
Umur 30 hingga 80 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07432958

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

Mengambil pesertaFasa 2
  • Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
Umur 40 hingga 85 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07514858

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Mengambil pesertaFasa 3
  • Quest Research Institute, Farmington Hills
Umur 50 hingga 85 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07174310

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Mengambil pesertaFasa 3
  • Quest Research Institute, Farmington Hills
Umur 45 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06944522

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Mengambil pesertaFasa 1
  • Quest Research Institute, Farmington Hills
Umur 40 hingga 80 · Semua jantina · Dikemas kini 5 Jun 2026 · NCT07422675

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
  • QUEST Research Institute, Farmington Hills
Umur 30 hingga 85 · Semua jantina · Dikemas kini 20 Apr 2026 · NCT06809400

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Mengambil pesertaFasa 4
  • Quest Research Institute, Farmington Hills
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2025 · NCT06765668

Kajian Penyakit Parkinson di bandar lain

Kajian lain di Farmington Hills

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.